Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab
BENGALURU, India, Feb. 8, 2024 /PRNewswire/ — Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon Ltd (BSE
Read MoreBENGALURU, India, Feb. 8, 2024 /PRNewswire/ — Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon Ltd (BSE
Read MoreSINGAPORE and AHMEDABAD, India, July 26, 2022 /PRNewswire/ — Prestige Biopharma Limited (KRX: 950210, hereafter referred to as “Prestige”) and Intas
Read More